SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : BCRX: Target practice for shorts
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: lifeisgood who wrote (73)9/7/1999 12:07:00 PM
From: Wolff  Read Replies (1) of 96
 
6 key points

1) Only 33% of pts. who get the flu contact their doctor within the critical 48 hour window (from GLX's web site re: Relenza)
2) The flu shot only works at preventing the flu 70 -85% of the time. (the medical letter)
3) No matter what, idiots who won't take a flu shot "because my aunt got the flu from it" or "I'm allergic to eggs" (just use a modified Penicillin RUSH protocol to "desensitize" them--look up Timothy J Sullivan of Emory Med School on Medline) will clog up all our waiting rooms between December and February.
4) Flu A has more serious complications than Flu B (Cecil's)
5) Flumadine is an overpriced amantidine, but is still WAY CHEAPER than NA inhibitors
6) BCRX was in a short squeeze (as heard another poster by his full service brokers at Smith Barney)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News